AIDS-related Funding Opportunity Announcements

NIMH Notices of Funding Opportunities

Request for Applications (RFA)

RFA-AI-24-023: U.S.-South Africa Program for Collaborative Biomedical Research – Phase 3 (HIV/AIDS) (R01 Clinical Trial Optional) 

Notice of Special Interest (NOSI)

NOT-MH-22-095: Notice of Special Interest (NOSI): NIMH Priorities on Research on Aggression and Violence Against Others 

NOT-MH-23-100: Notice of Data Sharing Policy for the National Institute of Mental Health 

NOT-MH-23-200: Innovative Technologies to develop novel tools to prevent and treat HIV in underserved populations 

NOT-MH-23-250: Notice of Special Interest (NOSI): Developmentally Tailored HIV Prevention and Care Research for Adolescents and Young Adults 

NOT-MH-23-265: Notice of Special Interest (NOSI): Mental Health Comorbidities in HIV Prevention and Treatment 

NOT-MH-23-270: Intersectional Stigma and Discrimination (ISD), or Other Social Determinants of Health (SSDOH) in HIV Prevention and Treatment 

NOT-MH-23-275: Implementation Science to Advance the United States HIV Prevention and Treatment Goals and the Global HIV Prevention and Treatment Targets 

NOT-MH-23-350: Notice of Special Interest (NOSI): Advancing Data Science Research in HIV: Responding to a Dynamic, Complex, and Evolving HIV Epidemic with Artificial Intelligence/Machine Learning 

Program Announcement with Special Receipt, Referral, and/or Review Considerations (PAR)

PAR-23-060: Formative and Pilot Intervention Research to Optimize HIV Prevention and Care Continuum Outcomes (R34 Clinical Trial Optional) 

PAR-23-061: Innovations to Optimize HIV Prevention and Care Continuum Outcomes (R21 Clinical Trial Option) 

PAR-23-062: Innovations to Optimize HIV Prevention and Care Continuum Outcomes (R01 Clinical Trial Option) 

PAR-24-164: Developmental AIDS Research Center on Mental Health and HIV/AIDS (P30 Clinical Trial Optional) 

PAR-24-165: AIDS Research Center on Mental Health and HIV/AIDS (P30 Clinical Trial Optional) 

PAR-24-233: NIMH Research Education Mentoring Program for HIV Researchers (R25 Clinical Trial Not Allowed) 

Co-Sponsored Funding Opportunities

Notice of Special Interest (NOSI)

NOT-AI-22-042: Notice of Special Interest (NOSI): Sustained Release of Antivirals for Treatment or Prevention of HIV or Treatment of Latent TB/HBV (SRATP) 

NOT-AI-22-056: Notice of Special Interest (NOSI): Opportunities for HIV Cure Interventions at the Time of ART 

NOT-AI-22-072: Notice of Special Interest (NOSI): Opportunities for HIV Cure Interventions at the Time of ART Initiation 

NOT-AI-24-059: Notice of Special Interest (NOSI): Ending the HIV Epidemic (EHE) 

NOT-CA-24-031: Notice of Special Interest (NOSI): Validation of Digital Health and Artificial Intelligence/Machine Learning Tools for Improved Assessment in Biomedical and Behavioral Research 

NOT-DA-21-060: Notice of Special Interest (NOSI): Reducing Stigma Related to Drug Use in Human Service Settings 

NOT-OD-24-146: Notice of Special Interest (NOSI): Improving Adherence to Treatment and Prevention Regimens and Maintenance of Health Behaviors to Promote Health 

Program Announcement with Special Receipt, Referral, and/or Review Considerations (PAR)

PAR-21-297: Multipurpose Prevention Technology: Novel Systemic Options for Young Adults 

PAR-22-145: Leveraging Health Information Technology (Health IT) to Address and Reduce Health Care Disparities (R01 Clinical Trial Optional) 

PAR-22-248: HIV/AIDS Scholars Using Nonhuman Primate (NHP) Models Program (K01 Independent Clinical Trial Not Allowed) 

PAR-22-252: Early Stage Investigator HIV/AIDS Research Using Nonhuman Primate (NHP) Models (R21 Clinical Trial Not Allowed) 

PAR-23-245: Personal Health Informatics for Delivering Actionable Insights to Individuals (R01 Clinical Trial Optional) 

PAR-24-091: Multidisciplinary Studies of HIV/AIDS and Aging (R01 Clinical Trial Optional) 

PAR-24-092: Multidisciplinary Studies of HIV/AIDS and Aging (R21 Clinical Trial Optional) 

PAR-24-295: Emerging Global Leader Award (K43 Independent Clinical Trial Required) 

PAR-24-296: Emerging Global Leader Award (K43 Independent Clinical Trial Not Allowed) 

PAR-25-143: Dissemination and Implementation Research in Health (R21 Clinical Trial Optional) 

PAR-25-144: Dissemination and Implementation Research in Health (R01 Clinical Trial Optional) 

PAR-25-233: Dissemination and Implementation Research in Health (R03 Clinical Trial Not Allowed)